Beyond thrombosis: the impact of tissue factor signaling in cancer

[1]  A. Dörner,et al.  Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes , 2020, Cardiovascular Diabetology.

[2]  N. von Bubnoff,et al.  Tissue factor activity on microvesicles from cancer patients , 2019, Journal of Cancer Research and Clinical Oncology.

[3]  T. Hassan,et al.  Tissue factor expression predicts outcome in children with neuroblastoma: A retrospective study , 2019, Oncology letters.

[4]  P. Wilgenbus,et al.  Myeloid cell–synthesized coagulation factor X dampens antitumor immunity , 2019, Science Immunology.

[5]  N. Mackman,et al.  Rivaroxaban does not affect growth of human pancreatic tumors in mice , 2019, Journal of thrombosis and haemostasis : JTH.

[6]  P. W. Janes,et al.  Eph receptor signalling: from catalytic to non-catalytic functions , 2019, Oncogene.

[7]  D. Scholtens,et al.  Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers , 2019, Scientific Reports.

[8]  R. Schuepbach,et al.  Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases , 2019, Thrombosis Journal.

[9]  A. Khorana,et al.  A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer , 2019, Oncology.

[10]  F. Giancotti,et al.  Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. , 2019, Cancer cell.

[11]  Miriam J. Johnson,et al.  Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex. , 2019, Thrombosis research.

[12]  M. Solh,et al.  Chimeric Antigen Receptor T-Cells: The Future Is Now , 2019, Journal of clinical medicine.

[13]  M. von Bergwelt-Baildon,et al.  Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy , 2019, Transfusion Medicine and Hemotherapy.

[14]  C. James,et al.  Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas , 2018, Clinical Cancer Research.

[15]  A. Kuliopulos,et al.  Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach , 2018, International journal of molecular sciences.

[16]  Tetsuro Ohba,et al.  Platelet‐Derived TGF‐β Induces Tissue Factor Expression via the Smad3 Pathway in Osteosarcoma Cells , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Androulla N. Miliotou,et al.  CAR T-cell Therapy: A New Era in Cancer Immunotherapy. , 2018, Current pharmaceutical biotechnology.

[18]  P. Sen,et al.  The Protease Activated Receptor2 Promotes Rab5a Mediated Generation of Pro-metastatic Microvesicles , 2018, Scientific Reports.

[19]  Amanda R. Campbell,et al.  Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON , 2018, Cancer Immunology Research.

[20]  James J. Morrow,et al.  Correction: Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence , 2018, Nature Medicine.

[21]  W. Ruf,et al.  Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. , 2018, Blood.

[22]  D. Fairlie,et al.  A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[23]  J. Rak,et al.  Inhibition of tissue factor signaling in breast tumour xenografts induces widespread changes in the microRNA expression profile. , 2017, Biochemical and biophysical research communications.

[24]  T. Stokol,et al.  Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1 , 2017, Front. Oncol..

[25]  G. Fontanini,et al.  miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells , 2017, Thrombosis.

[26]  N. Mackman,et al.  Cancer-associated pathways and biomarkers of venous thrombosis. , 2017, Blood.

[27]  Xuan Liu,et al.  Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer , 2017, Oncotarget.

[28]  H. Versteeg,et al.  Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells. , 2017, Thrombosis research.

[29]  Hui Zhao,et al.  Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma , 2017, Oncotarget.

[30]  Jingting Jiang,et al.  Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues. , 2017, Oncotarget.

[31]  M. Maoz,et al.  Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization , 2017, Oncotarget.

[32]  J. Trejo,et al.  Challenges and Opportunities in Protease-Activated Receptor Drug Development. , 2017, Annual review of pharmacology and toxicology.

[33]  Jie Yang,et al.  Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG mice , 2016, Oncotarget.

[34]  G. Landberg,et al.  Tissue Factor promotes breast cancer stem cell activity in vitro , 2016, Oncotarget.

[35]  Lianbo Yu,et al.  Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer , 2016, Oncotarget.

[36]  M. Shabani,et al.  Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy. , 2016, Current drug targets.

[37]  D. Kondziolka,et al.  Mutant IDH1 and thrombosis in gliomas , 2016, Acta Neuropathologica.

[38]  Omar Abdel-Wahab,et al.  Therapeutic targeting of splicing in cancer , 2016, Nature Medicine.

[39]  M. Sogayar,et al.  Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model. , 2016, Oncology letters.

[40]  K. Huber,et al.  Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation , 2016, Scientific Reports.

[41]  U. Landmesser,et al.  Tissue factor as a link between inflammation and coagulation. , 2016, Trends in cardiovascular medicine.

[42]  J. Rak,et al.  Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma , 2016, Oncotarget.

[43]  M. Kool,et al.  Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment. , 2016, The American journal of pathology.

[44]  Zhixiang Wang.  Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research , 2016, International journal of molecular sciences.

[45]  Y. Miyagi,et al.  High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors , 2015, Thrombosis and Haemostasis.

[46]  H. Versteeg,et al.  “Soluble Tissue Factor” in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation , 2015, Seminars in Thrombosis & Hemostasis.

[47]  R. Brekken,et al.  Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. , 2015, Cancer research.

[48]  D. Kirchhofer,et al.  Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide‐stimulated monocytes , 2015, Journal of thrombosis and haemostasis : JTH.

[49]  A. Siegbahn,et al.  Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets , 2015, Diabetologia.

[50]  A. Eisenreich,et al.  The role of tissue factor isoforms in cancer biology , 2015, International journal of cancer.

[51]  C. Lindsell,et al.  Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype , 2015, Annals of Surgical Oncology.

[52]  J. Griffin,et al.  EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. , 2015, Blood.

[53]  P. Parren,et al.  High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody–Drug Conjugates , 2015, Molecular Cancer Therapeutics.

[54]  J. Hansen,et al.  BMP-7 induces TF expression in human monocytes by increasing F3 transcriptional activity. , 2015, Thrombosis research.

[55]  P. Blackshear,et al.  PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression. , 2014, Blood.

[56]  J. Bergquist,et al.  The Eph Tyrosine Kinase Receptors EphB2 and EphA2 Are Novel Proteolytic Substrates of Tissue Factor/Coagulation Factor VIIa* , 2014, The Journal of Biological Chemistry.

[57]  John Francis,et al.  An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors. , 2014, Cancer research.

[58]  G. Bourque,et al.  Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations , 2014, Proceedings of the National Academy of Sciences.

[59]  A. Siegbahn,et al.  Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor , 2013, Thrombosis and Haemostasis.

[60]  Thomas H. Smith,et al.  Cofactoring and Dimerization of Proteinase-Activated Receptors , 2013, Pharmacological Reviews.

[61]  E. Pasquale,et al.  Eph receptor signaling and ephrins. , 2013, Cold Spring Harbor perspectives in biology.

[62]  A. Pries,et al.  Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. , 2013, Oncology reports.

[63]  P. Reitsma,et al.  Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner , 2013, Proceedings of the National Academy of Sciences.

[64]  Biao Wu,et al.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620 , 2013, Tumor Biology.

[65]  C. Esmon,et al.  Endothelial Protein C Receptor Function in Murine and Human Breast Cancer Development , 2013, PloS one.

[66]  Luyong Zhang,et al.  Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor , 2013, Acta oncologica.

[67]  Biao Wu,et al.  Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620 , 2013, Tumor Biology.

[68]  A. Maraveyas,et al.  p38α phosphorylates serine 258 within the cytoplasmic domain of tissue factor and prevents its incorporation into cell-derived microparticles. , 2013, Biochimica et biophysica acta.

[69]  Hyun Beom Song,et al.  Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway. , 2012, Oncology reports.

[70]  Sheng Lin,et al.  Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+ Ovarian Cancer Stem‐Like Cells via NF‐κB‐Mediated MMP‐9 Upregulation , 2012, Stem cells.

[71]  K. Preissner,et al.  TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. , 2012, American journal of respiratory cell and molecular biology.

[72]  Ligong Liu,et al.  An antagonist of human protease activated receptor‐2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen‐induced arthritis in rats , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  N. Chegini,et al.  miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. , 2012, Molecular endocrinology.

[74]  Lei Zhao,et al.  Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. , 2012, Blood.

[75]  P. Reitsma,et al.  The relationship between tissue factor and cancer progression: insights from bench and bedside. , 2012, Blood.

[76]  M. Hollenberg,et al.  Targeting proteinase-activated receptors: therapeutic potential and challenges , 2012, Nature Reviews Drug Discovery.

[77]  S. Sharifi,et al.  Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[78]  J. Duanmu,et al.  Effective treatment of human lung cancer by targeting tissue factor with a factor VII-targeted photodynamic therapy. , 2011, Current cancer drug targets.

[79]  J. Bastarache,et al.  Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells , 2011, Experimental lung research.

[80]  John Yang,et al.  Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer. , 2011, The American journal of pathology.

[81]  N. Mackman,et al.  Microparticles in Hemostasis and Thrombosis , 2011, Circulation research.

[82]  Lei Wang,et al.  Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis , 2011, International Journal of Colorectal Disease.

[83]  S. Iliceto,et al.  Long-term use of vitamin K antagonists and incidence of cancer: a population-based study. , 2011, Blood.

[84]  A. Siegbahn,et al.  Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1). , 2011, Thrombosis research.

[85]  H. Versteeg,et al.  Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. , 2010, Blood.

[86]  C. Esmon,et al.  The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors* , 2010, The Journal of Biological Chemistry.

[87]  Haijun Yu,et al.  MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.

[88]  Zhiwei Hu,et al.  Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer , 2010, BMC Immunology.

[89]  Giang T Le,et al.  Novel agonists and antagonists for human protease activated receptor 2. , 2010, Journal of medicinal chemistry.

[90]  C. Horbinski,et al.  Live free or die: tales of homeless (cells) in cancer. , 2010, The American journal of pathology.

[91]  J. Rak,et al.  Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. , 2010, Blood.

[92]  A. Eisenreich,et al.  Regulation and differential role of the tissue factor isoforms in cardiovascular biology. , 2010, Trends in cardiovascular medicine.

[93]  A. Akhmedov,et al.  PDGF-CC induces tissue factor expression: role of PDGF receptor α/β , 2010, Basic Research in Cardiology.

[94]  J. Rak,et al.  Role of the tissue factor pathway in the biology of tumor initiating cells. , 2010, Thrombosis research.

[95]  Y. Gruel,et al.  Tumor expression of alternatively spliced tissue factor is a prognostic marker in non‐small cell lung cancer , 2010, Journal of thrombosis and haemostasis : JTH.

[96]  K. Mann,et al.  Carbohydrates and Activity of Natural and Recombinant Tissue Factor* , 2009, The Journal of Biological Chemistry.

[97]  J. Rak,et al.  Tissue factor and cancer stem cells: is there a linkage? , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[98]  E. Jordanova,et al.  Alternatively spliced tissue factor induces angiogenesis through integrin ligation , 2009, Proceedings of the National Academy of Sciences.

[99]  E. Lemarié,et al.  Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. , 2009, Clinical chemistry.

[100]  L. Rydén,et al.  Evidence for tissue factor phosphorylation and its correlation with protease‐activated receptor expression and the prognosis of primary breast cancer , 2009, International journal of cancer.

[101]  E. Conway,et al.  Coagulation and innate immune responses: can we view them separately? , 2009, Blood.

[102]  R. Nieuwland,et al.  Human alternatively spliced tissue factor is not secreted and does not trigger coagulation , 2009, Journal of thrombosis and haemostasis : JTH.

[103]  S S Cross,et al.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease , 2009, British Journal of Cancer.

[104]  D. Gingras,et al.  c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration. , 2009, Carcinogenesis.

[105]  Erwin G. Van Meir,et al.  Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. , 2009, Cancer research.

[106]  M. Humphries,et al.  Linking integrin conformation to function , 2009, Journal of Cell Science.

[107]  A. Abo,et al.  rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor , 2009, Clinical Cancer Research.

[108]  A. Guha,et al.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. , 2008, Cancer research.

[109]  H. Versteeg,et al.  Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. , 2008, Cancer research.

[110]  P. Liaw,et al.  Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes1 , 2008, The Journal of Immunology.

[111]  C. Alvarado,et al.  Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells , 2008, BMC Cancer.

[112]  G. Soff,et al.  Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. , 2008, Seminars in thrombosis and hemostasis.

[113]  J. Rak,et al.  Elevated tissue factor procoagulant activity in CD133‐positive cancer cells , 2007, Journal of Thrombosis and Haemostasis.

[114]  U. Pendurthi,et al.  Tissue factor activation: is disulfide bond switching a regulatory mechanism? , 2007, Blood.

[115]  A. Siegbahn,et al.  TF/FVIIa Transactivate PDGFR&bgr; to Regulate PDGF-BB–Induced Chemotaxis in Different Cell Types: Involvement of Src And PLC , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[116]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[117]  Zhiwei Hu,et al.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. , 2007, Blood.

[118]  W. Ruf,et al.  Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[119]  Jun Fang,et al.  [Regulation of tissue factor expression by anti-oncogene PTEN in human neuroblastoma cell line]. , 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[120]  Ralph H. Hruban,et al.  Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer , 2007, Clinical Cancer Research.

[121]  K. Picha,et al.  CNTO 859, a humanized anti‐tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models , 2007, International journal of cancer.

[122]  M. Grandoch,et al.  Alternatively spliced human tissue factor (asHTF) is not pro-coagulant , 2006, Thrombosis and Haemostasis.

[123]  S. Karpatkin,et al.  Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. , 2006, Cancer cell.

[124]  B. M. Mueller,et al.  Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. , 2006, Biochemical and biophysical research communications.

[125]  F. Rickles.  Mechanisms of Cancer-Induced Thrombosis in Cancer , 2006, Pathophysiology of Haemostasis and Thrombosis.

[126]  F. Boulton.  A hundred years of cascading – started by Paul Morawitz (1879–1936), a pioneer of haemostasis and of transfusion , 2006, Transfusion medicine.

[127]  E. Bjørklid,et al.  Sources of tissue factor. , 2006, Seminars in thrombosis and hemostasis.

[128]  E. Turner,et al.  Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity , 2005, Journal of Translational Medicine.

[129]  Hugo A Katus,et al.  Interleukin-10 Suppresses Tissue Factor Expression in Lipopolysaccharide-Stimulated Macrophages via Inhibition of Egr-1 and a Serum Response Element/MEK-ERK1/2 Pathway , 2005, Circulation research.

[130]  A. Akhmedov,et al.  Histamine Induces Tissue Factor Expression Implications for Acute Coronary Syndromes , 2005, Circulation.

[131]  Xiao-dong Shao,et al.  Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue factor (TF) in SGC-7901 gastric cancer cells , 2005, Cancer biology & therapy.

[132]  N. Heveker,et al.  Tissue factor enhances protease‐activated receptor‐2‐mediated factor VIIa cell proliferative properties , 2005, Journal of thrombosis and haemostasis : JTH.

[133]  Erwin G. Van Meir,et al.  PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. , 2005, Cancer research.

[134]  S. Shirasawa,et al.  Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.

[135]  A. Falanga.  Thrombophilia in cancer. , 2005, Seminars in thrombosis and hemostasis.

[136]  AlbertSchömig,et al.  Tissue Factor Cytoplasmic Domain Stimulates Migration by Activation of the GTPase Rac1 and the Mitogen-Activated Protein Kinase p38 , 2005 .

[137]  H. Katus,et al.  Platelet-Derived Growth Factor Induces Tissue Factor Expression in Vascular Smooth Muscle Cells via Activation of Egr-1 , 2004, Hypertension.

[138]  Y. Takada,et al.  Cross-talk of integrin α3β1 and tissue factor in cell migration , 2004 .

[139]  H. Prydz,et al.  The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells , 2004, Thrombosis and Haemostasis.

[140]  W. Ruf,et al.  Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain* , 2004, Journal of Biological Chemistry.

[141]  P. Carmeliet,et al.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.

[142]  V. Bobek,et al.  Antitumor and antimetastatic effect of warfarin and heparins. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[143]  D. Richel,et al.  FVIIa:TF Induces Cell Survival via G12/G13-Dependent Jak/STAT Activation and BclXL Production , 2004, Circulation research.

[144]  U. Pendurthi,et al.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. , 2004, Blood.

[145]  D. Richel,et al.  Coagulation factors VIIa and Xa inhibit apoptosis and anoikis , 2004, Oncogene.

[146]  W. Ruf,et al.  Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. , 2003, Blood.

[147]  S. Fan,et al.  Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[148]  Lan Ge,et al.  A β-Arrestin-dependent Scaffold Is Associated with Prolonged MAPK Activation in Pseudopodia during Protease-activated Receptor-2-induced Chemotaxis* , 2003, Journal of Biological Chemistry.

[149]  S. Gammeltoft,et al.  Antiapoptotic effect of coagulation factor VIIa. , 2003, Blood.

[150]  R. Peters,et al.  Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. , 2003, Journal of the American College of Cardiology.

[151]  T. Hembrough,et al.  Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.

[152]  Y. Nemerson,et al.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein , 2003, Nature Medicine.

[153]  G. Neufeld,et al.  Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[154]  D. Richel,et al.  VIIa/Tissue Factor Interaction Results in a Tissue Factor Cytoplasmic Domain-independent Activation of Protein Synthesis, p70, and p90 S6 Kinase Phosphorylation* , 2002, The Journal of Biological Chemistry.

[155]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[156]  B. Su,et al.  Tissue factor expression and angiogenesis in human glioma. , 2002, Clinical biochemistry.

[157]  C. Miki,et al.  Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer , 2002, American journal of hematology.

[158]  Zhiwei Hu,et al.  Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[159]  P. Carmeliet,et al.  Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. , 2001, Biochemical and biophysical research communications.

[160]  J. Stam,et al.  Factor VIIa/Tissue Factor-induced Signaling via Activation of Src-like Kinases, Phosphatidylinositol 3-Kinase, and Rac* , 2000, The Journal of Biological Chemistry.

[161]  Zhiwei Hu,et al.  Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[162]  E. Bachli.  History of tissue factor. , 2000 .

[163]  Esther Bächli, MD.  Historical review , 2000 .

[164]  S. Schulman,et al.  Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. , 2000, The New England journal of medicine.

[165]  A. Wolberg,et al.  Deencryption of cellular tissue factor is independent of its cytoplasmic domain. , 2000, Biochemical and biophysical research communications.

[166]  R. Bordet,et al.  Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. , 2000, Circulation.

[167]  P. Humphrey,et al.  Tissue factor expression and angiogenesis in human prostate carcinoma. , 2000, Human pathology.

[168]  H. Prydz,et al.  Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene* , 1999, The Journal of Biological Chemistry.

[169]  P. Nawroth,et al.  Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[170]  Zhiwei Hu,et al.  Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[171]  R. Homer,et al.  Role of Tissue Factor in Metastasis: Functions of the Cytoplasmic and Extracellular Domains of the Molecule , 1999, Thrombosis and Haemostasis.

[172]  T. Luther,et al.  Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells. , 1999, Experimental cell research.

[173]  O. Matsubara,et al.  Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis , 1999, British Journal of Cancer.

[174]  W. Ruf,et al.  Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. , 1998, The Journal of clinical investigation.

[175]  Y. Miyagi,et al.  A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280 , 1998, The Journal of cell biology.

[176]  J. Jesty,et al.  Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation , 1998 .

[177]  M. Volm,et al.  Tissue‐factor expression in human non‐small‐cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis , 1998, International journal of cancer.

[178]  T S Edgington,et al.  The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. , 1998, Journal of molecular biology.

[179]  F. Neumann,et al.  Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[180]  J. Fallon,et al.  Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. , 1997, The Journal of clinical investigation.

[181]  T. K. Hunt,et al.  Mice lacking the thrombin receptor, PAR1, have normal skin wound healing. , 1997, The American journal of pathology.

[182]  J. Grande,et al.  Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer : Paracrine regulation by carcinoma cell-derived members of the transforming growth factor β family , 1996 .

[183]  P. Carmeliet,et al.  Role of tissue factor in embryonic blood vessel development , 1996, Nature.

[184]  M. Ultsch,et al.  The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. , 1996, Journal of molecular biology.

[185]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[186]  P. Wright,et al.  Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. , 1995, The Biochemical journal.

[187]  W. Konigsberg,et al.  Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[188]  N. Lemoine,et al.  Tissue factor expression correlates with histological grade in human pancreatic cancer , 1995, The British journal of surgery.

[189]  B. Giusti,et al.  Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. , 1995, Blood.

[190]  C. Birr,et al.  Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein , 1994 .

[191]  A. Guha,et al.  Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. , 1993, The Journal of clinical investigation.

[192]  T S Edgington,et al.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[193]  S. Roy,et al.  The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. , 1992, The Journal of biological chemistry.

[194]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[195]  R. Harris,et al.  Post-translational modifications of recombinant human tissue factor. , 1990, Thrombosis research.

[196]  S. Rapaport,et al.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. , 1990, Thrombosis research.

[197]  W. Konigsberg,et al.  Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. , 1988, Biochemistry.

[198]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[199]  P. Morawitz,et al.  Die Chemie der Blutgerinnung , 1905 .

[200]  G. Fong,et al.  Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice. , 2015, Methods in molecular biology.

[201]  B. Aronow,et al.  Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma , 2014, International journal of cancer.

[202]  Tanja Sušec,et al.  Historical Review , 1917, Acta Cytologica.

[203]  Zuoren Yu,et al.  Cancer stem cells. , 2012, The international journal of biochemistry & cell biology.

[204]  Y. Takada,et al.  Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth , 2014 .

[205]  A. Siegbahn,et al.  Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. , 2008, Thrombosis research.

[206]  S. Crawford,et al.  Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. , 2007, Thrombosis research.

[207]  R. Deschenes,et al.  Palmitoylation: policing protein stability and traffic , 2007, Nature Reviews Molecular Cell Biology.

[208]  Y. Takada,et al.  Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. , 2004, Molecular biology of the cell.

[209]  P. Libby,et al.  CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. , 2000, The American journal of pathology.

[210]  Steven D. Carson,et al.  Tissue Factor Encryption/de-encryption Is not Altered in the Absence of the Cytoplasmic Domain , 2000, Thrombosis and Haemostasis.

[211]  J. Grande,et al.  Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. , 1996, Cancer research.

[212]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[213]  K. Nakagawa,et al.  Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipopolysaccharide. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.

[214]  C. Birr,et al.  Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. , 1994, Blood.

[215]  T. Drake,et al.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. , 1989, The American journal of pathology.